{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:23:07Z","timestamp":1789125787976,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMC"],"published-print":{"date-parts":[[2026,9,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction\/Objective:<\/jats:title>\n                    <jats:p>Current cancer chemotherapy is limited by severe adverse effects,\npoor selectivity toward malignant cells, and the emergence of multidrug resistance, highlighting\nthe need for novel therapeutic strategies with enhanced potency and safety. Sulfonyl-containing\ncompounds and sulfonamide derivatives have attracted sustained attention as anticancer scaffolds\nbecause of their structural diversity, favorable physicochemical properties, and broad pharmacological\nprofiles. This review critically examines how structural variation within aromatic sulfonamides\ncontrols target engagement, anticancer activity, and translational potential. Rather than cataloguing\nindividual derivatives, it integrates cross-family structure\u2013activity relationships with mechanistic\nevidence involving carbonic anhydrases, tubulin dynamics, survival signaling, apoptosis, and tumorassociated\nmetabolic adaptation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Recent experimental and preclinical studies were reviewed, with special emphasis on sulfonyl\nand sulfonamide derivatives as multifunctional pharmacophores and their emerging role in\ncancer therapy, supported by extensive chemical and pharmacological evidence. Emphasis was placed\non heterocyclic sulfonyl compounds and macrocyclic hybrid systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Several sulfonamide derivatives have demonstrated potent antiproliferative activity against\na broad range of human cancer cell lines, including MCF-7 and MIA PaCa-2, by interacting with\nmultiple targets and disrupting pathways involved in tumor growth and survival. Calixarenesulfonyl\nhybrids demonstrate selective and potent cytotoxicity against several cancer cell lines, including\nbreast and pancreatic cancer models. These compounds inhibit tubulin dynamics, reduce the\nproliferation of multiple human cancer cell lines, induce apoptosis, and modulate molecular targets\nassociated with the phosphoinositide 3-kinase\/protein kinase B signaling pathway. The clinical success\nof sulfonamide-containing agents further validates this pharmacophore in oncology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The available evidence indicates that structural optimization of aromatic sulfonamides can\nimprove antiproliferative activity and target selectivity, although cellular potency alone is insufficient\nto establish therapeutic relevance. Direct target validation, mechanistic characterization, tumor selectivity,\nand pharmacokinetic assessment remain necessary to distinguish pharmacologically relevant activity\nfrom non-specific cytotoxicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Aromatic sulfonamides constitute a chemically adaptable platform from which compounds\nacting on carbonic anhydrases, tubulin, survival signaling, and apoptosis-related processes\nhave been developed. The available evidence supports their continued investigation in anticancer\ndrug discovery; however, multi-target activity should be considered advantageous only when target\nengagement, tumor selectivity, and resistance-relevant effects are experimentally distinguished from\nnon-specific cytotoxicity. Future development will depend on biomarker-guided evaluation, direct\nmechanistic validation, and early assessment of pharmacokinetic and safety liabilities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0109298673477523260828075423","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:03:43Z","timestamp":1789124623000},"source":"Crossref","is-referenced-by-count":0,"title":["Aromatic Sulfonamides Emerge as a Promising Frontier in Advanced Cancer Therapy"],"prefix":"10.2174","volume":"33","author":[{"given":"Faiz","family":"Ullah","sequence":"first","affiliation":[{"name":"Department of Chemistry Quaid I Azam University, Islamabad 45320, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Ullah","sequence":"additional","affiliation":[{"name":"Department of Wildlife &amp; Ecology Universityof Veterinary and Animal Science (UVAS) Lahore, Lahore 54000, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Mustaqeem","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Fayyaz","family":"ur Rehman","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, University of Sargodha, Sargodha 40100, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sania","family":"Nazir","sequence":"additional","affiliation":[{"name":"Woman University of Azad Jammu &amp; Kashmir Bag, Azad Jammu &amp; Kashmir 12500, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra K\u00fcpeli","family":"Akkol","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330, Etiler, Ankara, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Junaid","family":"Tariq","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Capital University of Science and Technology, 46000, Islamabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ibrar","family":"Khan","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Capital University of Science and Technology, 46000, Islamabad, Pakistan"},{"name":"Pharmacological Sciences Research Lab, Department of Pharmacy, Faculty of Biological Sciences, Quaid I Azam University, Islamabad 45320, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeliha","family":"Selamoglu","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Medicine Faculty, Ni\u011fde Omer Halisdemir University, Nigde, T\u00fcrkiye"},{"name":"Western Caspian University, Baku, Azerbaijan"},{"name":"Khoja Akhmet Yassawi International Kazakh-Turkish University, Faculty of Sciences, Department of Biology, Central Campus, Turkestan, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2790-2544","authenticated-orcid":true,"given":"Eduardo","family":"Sobarzo-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n en Ingenier\u00eda de Materiales-CIIMAT, Facultad de Medicina y Ciencias de la Salud, Universidad Central de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673477523260828075423","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258125\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673477523260828075423","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:03:49Z","timestamp":1789124629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258125\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673477523260828075423","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,8]]}}}